Previous Article | Next Article ![]()
Infection and Immunity, August 1999, p. 3773-3779, Vol. 67, No. 8
INSERM U4771 and
Institut de Rhumatologie,
Received 25 February 1999/Returned for modification 16 April
1999/Accepted 11 May 1999
Yersinia-induced reactive arthritis is highly
associated with HLA-B27, the role of which in defense against the
triggering bacteria remains unclear. The aim of this study was to
examine the capacity of rats transgenic for HLA-B27 to mount a
cytotoxic T-lymphocyte (CTL) response against Y. pseudotuberculosis and to determine the influence of the HLA-B27
transgene on this response. Rats transgenic for HLA-B*2705 and human
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Cytotoxic T-Cell-Mediated Response against
Yersinia pseudotuberculosis in HLA-B27 Transgenic
Rat
2-microglobulin of the 21-4L line, which do not
spontaneously develop disease, and nontransgenic syngeneic Lewis (LEW)
rats were infected with Y. pseudotuberculosis. Lymph node
cells were restimulated in vitro, and the presence of for Y. pseudotuberculosis-specific CTLs against infected targets was
determined. Infection of 21-4L rats triggered a CD8+ T
cell-mediated cytotoxic response specific for Y. pseudotuberculosis. Analysis of this response demonstrated
restriction by an endogenous major histocompatibility complex molecule.
However, no restriction by HLA-B27 was detected. In addition, kinetics
studies revealed a weaker anti-Yersinia CTL response in
21-4L rats than in nontransgenic LEW rats, and the level of
cytotoxicity against 21-4L lymphoblast targets sensitized with Y. pseudotuberculosis was lower than that against nontransgenic LEW
targets. We conclude that HLA-B27 transgenic rats mount a CTL response
against Y. pseudotuberculosis that is not restricted by
HLA-B27. Yet, HLA-B27 exerts a negative effect on the level of this
response, which could contribute to impaired defense against
Yersinia.
*
Corresponding author. Mailing address: Institut de
Rhumatologie and INSERM U477, Hôpital Cochin, 27 rue du
Faubourg Saint-Jacques, 75674, Paris, France. Phone:
33-142341829. Fax: 33-143261156. E-mail:
maxime.breban{at}cch.ap-hop-paris.fr.
Infection and Immunity, August 1999, p. 3773-3779, Vol. 67, No. 8
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»